Scientist Arjan Griffioen leads cancer treatment innovation with lab and startup (Amsterdam UMC)
Could an innovative cancer treatment be used as a preventative vaccine? Arjan Griffioen and his team are determined to find out. These scientists have been developing proteins that specifically target cancer cells in the blood, leaving healthy tissue untouched. Every step of this journey—from vision to execution—has relied on the team’s dedication, as well as essential funding and investment. Spoiler alert: bringing the new treatment to market is not done overnight! Curious about the steps necessary? Watch the video to hear the full story by Arjan Griffioen and Else Huijbers.
Explore other Stories:
COMCRIM – Jill Coster van Voorhout PhD, associate professor
COMCRIM: COMbatting CRIMes that undermine the rule of law in a smart and comprehensive manner, in a financial public-private partnership and through artificial intelligence – with a focus on human trafficking, money laundering and corruption Contactpersoon: Mw. mr. dr. drs. J.E.B. (Jill) Coster van Voorhout PhD, associate professor.
Entrepreneurship journey of VU spin-off Optics11
Talking on Dutch television about Optics11 and the collaboration with the Dutch Ministry of Defence, raising €5 million in funding for superior life science instruments and selling products worldwide: Vrije Universiteit spin-off Optics11 is scaling up. At IXA, we were curious to find out about their journey.
Dr. Alexander Kostenko’s tips for creating a start-up
What are the first steps when beginning a start-up? IXA sat down with postdoctoral researcher and entrepreneur Alexander Kostenko to obtain advice for starting academic entrepreneurs. Starting a company is “really hard,” explains Alexander Kostenko with a smile. Alexander found his start-up Photosynthetic in 2019 so he could build high-end 3D printers that make micron-sized objects […]